Biologics

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

 November 20, 2023 | News

Groundbreaking milestone as the United Kingdom MHRA greenlights CASGEVY™, heralding a new era in CRISPR-based gene editing therapies

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...

 November 17, 2023 | News

Cytiva Revolutionizes Protein Purification with Universal Affinity Technology

New tag technology is self-cleaving and traceless, helping drug developers and manufacturers obtain pure proteins without remaining tag residues. New af...

 November 16, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

 Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced the successful completion ...

 November 16, 2023 | News

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

As the use of precision oncology therapeutics continues to advance in China, the partnership will provide AmoyDx with access to additional, highly validate...

 November 15, 2023 | News

Ajinomoto Group Makes Strategic Move into Gene Therapy with $750 Million Acquisition of Forge Biologics, Bolstering Healthcare Portfolio for Exponential Growth

In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...

 November 15, 2023 | News

LGC acquires PolyDesign

PolyDesign manufacture and supply customers with their ‘PolyFrit’ products from their site in Redmond, Washington.   The proprietary frit t...

 November 15, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC  with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

 November 15, 2023 | News

Illumina Launches Global Health Access Initiative to Boost Pathogen Sequencing in Low- and Middle-Income Countries

 Illumina Inc, a global leader in DNA sequencing and array-based technologies, announced  the launch of the Global Health Access Initiative to su...

 November 14, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

 November 14, 2023 | News

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

 NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world&rs...

 November 10, 2023 | News

Porton Advanced Partners with BioMap to Boost AAV Gene Therapy with AI Models

The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors, and expanding the application of AI models in ...

 November 09, 2023 | News

BioRay Starts Phase I Study for BRY812, Targeted Antibody Drug Conjugate

LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...

 November 08, 2023 | News

Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors

BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China     Biotheus Inc. ("Biotheus"),...

 November 07, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close